Statements and Comment Letters
November 14, 2023 – PAVC submits statement for the record following Senate Finance Subcommittee hearing on Medicare telehealth permanency | Read the Full Statement
October 31, 2023 – PAVC and other stakeholders send letter to House leaders, urging action on the Telehealth Expansion Act of 2023 (H.R. 1843) | Read the Full Letter
October 17, 2023 – PAVC and other stakeholders send letter to Senate leaders, urging action on the Telehealth Expansion Act of 2023 (S. 1001) | Read the Full Letter
October 4, 2023 – PAVC submits comments in response to House Ways and Means Committee request for information on rural health care | Read the Full Letter
September 15, 2023 – PAVC and other stakeholders send letter to congressional leaders, urging action on the Telehealth Benefit Expansion for Workers Act (H.R. 824) | Read the Full Letter
September 8, 2023 – PAVC submits comments to CMS focused on telehealth policies, in response to the proposed CY 2024 Medicare Physician Fee Schedule (PFS) rule | Read the Full Comment
June 6, 2023 – PAVC and other stakeholders send letter of support to House Ways and Means Committee leaders in support of the Telehealth Expansion Act (H.R. 1843), to permanently extend the safe harbor for first-dollar coverage for telehealth services for those with HSA-eligible HDHPs | Read the Full Letter
March 29, 2023 – PAVC and other stakeholders send letter of support to sponsors of the Telehealth Benefit Expansion for Workers Act (H.R. 824) | Read the Full Letter
March 29, 2023 – PAVC submits comments on two Drug Enforcement Agency (DEA) proposed rules related to the prescription of controlled substances, including buprenorphine, without a requirement for an in-person visit | Read the Full Comment
January 30, 2023 – PAVC submits comments on the bipartisan CONNECT for Health Act | Read the Full Comment
January 26, 2023 – PAVC signs stakeholder letter to CMS on extending telehealth codes through CY 2024 | Read the Full Letter
Issue Briefs and Advocacy Materials
CMS releases final Medicare Physician Fee Schedule rule for CY 2024, including virtual care provisions | View the Comprehensive Summary
DEA proposes limited post-PHE telemedicine prescription of controlled substances | View the Special Report
Snapshot of expanded access to virtual care during the pandemic | View the Infographic
Repealing the in-person requirement for mental telehealth services | Read the Full Brief
Congress must act to ensure continued access to telehealth services for those with HSA-eligible HDHPs
Read background document | View the Infographic